W. R. Grace & Company Introduces Disposable Purification Solution To Lower Cost And Accelerate Drug Development For Biotech

Published: Mar 24, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

COLUMBIA, Md.--(BUSINESS WIRE)--W. R. Grace & Co. (NYSE: GRA) has introduced ProVanceā„¢ pre-packed columns, a portfolio of products for cost-effective purification of biologic drugs, specifically monoclonal antibodies (mAbs). Monoclonal antibodies are key therapeutic agents used to treat rheumatoid arthritis, cancer and other diseases. Currently in the U.S., mAbs constitute the single largest biologics product category in the clinical development pipeline. Purification of these agents is a critical step in drug development.

Help employers find you! Check out all the jobs and post your resume.

Back to news